Compare Licensed Weight Loss Treatments Available Today
Understanding Ozempic, Wegovy and Mounjaro for Prescription Weight Loss
When exploring prescription weight loss options, it's crucial to understand the distinctions between Ozempic, Wegovy, and Mounjaro. Wegovy (semaglutide) is specifically licensed for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, representing the gold standard in prescription weight loss treatment. Ozempic, whilst containing the same active ingredient as Wegovy, is licensed exclusively for type 2 diabetes treatment and cannot legally be promoted for weight management purposes in the UK.
Mounjaro (tirzepatide) offers a dual-mechanism approach, targeting both GIP and GLP-1 receptors compared to Wegovy's GLP-1-only action. Both Wegovy and Mounjaro are available from EverydayMeds following clinical assessment, with your prescriber helping determine which treatment aligns with your medical history and weight management goals. Our GPhC-registered pharmacy ensures you receive genuine, licensed treatments with proper medical oversight throughout your weight loss journey.
Prescription Weight Loss Treatment Pricing and Bundles
EverydayMeds offers transparent pricing for all prescription weight loss treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose (after applying code FIRST40 for new customers). Our dose escalation follows the licensed protocol: 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Returning customers benefit from code DOSE25 at checkout, with all prices representing the final amount after discount application.
Our convenient bundle options streamline your weight loss journey, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99, perfect for your first two months of treatment. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 provides three months of step-up dosing, whilst our Ultimate Stability Trio delivers three months of maintenance 2.4mg doses for £649.99. These bundles ensure consistent supply and reduce ordering frequency during your prescription weight loss programme.
Clinical Evidence Supporting Ozempic, Wegovy and Mounjaro Effectiveness
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in prescription weight loss. In the pivotal STEP 1 trial (Wilding et al., NEJM, 2021), participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, showing its dual GIP/GLP-1 receptor mechanism in weight management contexts. Both treatments require prescription-only medicine status and work alongside a reduced-calorie diet and increased physical activity. Your EverydayMeds prescriber will review the clinical evidence relevant to your individual circumstances during your assessment.
How Wegovy and Mounjaro Work for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone that regulates blood sugar and appetite. This mechanism reduces hunger signals to your brain whilst promoting feelings of fullness after smaller meals, making it easier to maintain a reduced-calorie diet. The treatment may also reduce food cravings by affecting brain appetite centres, supporting long-term behaviour change essential for sustainable weight management. Mounjaro's dual receptor approach targets both GIP and GLP-1 pathways, potentially offering enhanced metabolic effects through its broader mechanism of action. Both treatments require once-weekly injection and work optimally when combined with lifestyle modifications including regular physical activity.
Simple Ordering Process for Prescription Weight Loss Treatment
Starting your prescription weight loss journey with EverydayMeds takes just three minutes through our comprehensive clinical assessment questionnaire. Our specialist prescribers review your medical history, current medications, and weight management goals, with standard reviews completed within three working days (express 24-hour service available). Once approved, your treatment ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The entire process operates through our GPhC-registered pharmacy (#9012878), ensuring full regulatory compliance and clinical safety standards. You'll receive injection guidance, dose escalation schedules, and ongoing support throughout your treatment programme.
Storage and Practical Considerations for Wegovy vs Mounjaro
Wegovy offers superior storage flexibility, maintaining potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves invaluable for travel, work, or lifestyle situations where consistent refrigeration isn't assured. Both treatments use pre-filled FlexTouch pens for convenient self-injection, with dose escalation following strict protocols to minimise side effects. Wegovy's escalation schedule spans 16 weeks to reach maintenance dosing, whilst proper storage ensures medication effectiveness throughout your prescription weight loss programme. Your treatment area should be rotated between thighs, abdomen, or upper arms, with injection timing flexible within your chosen weekly schedule.
Comparing Prescription Weight Loss Mechanisms and Outcomes
The fundamental difference between Wegovy and Mounjaro lies in their receptor targets: Wegovy's selective GLP-1 action versus Mounjaro's dual GIP/GLP-1 approach. This mechanistic distinction influences how each treatment affects appetite regulation, gastric emptying, and metabolic parameters. Neither treatment should be considered universally superior, as individual responses vary based on genetics, lifestyle factors, and concurrent health conditions.
Both treatments demonstrate substantial efficacy in clinical trials, though direct comparisons remain limited due to different study populations and endpoints. Your EverydayMeds prescriber considers your complete medical profile when recommending between available prescription weight loss options. The key to success with either treatment lies in consistent adherence to dosing schedules and commitment to lifestyle modifications including dietary changes and regular exercise.
Start Your Prescription Weight Loss Journey Today
Ready to explore prescription weight loss treatment with expert medical support? EverydayMeds makes accessing Wegovy, Mounjaro, and other licensed treatments straightforward through our clinical assessment process. New customers save with code FIRST40, whilst returning customers benefit from code DOSE25 at checkout. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine treatments with comprehensive prescriber support throughout your weight management programme. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards medically supervised weight loss. Don't delay – start your transformation with the UK's trusted prescription weight loss specialists today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
